A research group led by Nagoya University's Graduate School of Engineering has uncovered how rapid tendon regeneration occurs in newts. The research, published in the Journal of Orthopaedic Research, compared the regeneration ...
Nov 29, 2023
0
15
Cancer cells are often a mess of mutations. About 20% to 25% of cancers involve mutations in a complex of molecules called SWI/SNF. Yet drugs designed to block SWI/SNF activity haven't always worked as expected. Researchers ...
Nov 3, 2023
0
42
To improve therapies for cancer and other diseases, researchers strive to identify tissue-specific therapeutic targets and diagnostic biomarkers in every patient. Identifying specific targets and biomarkers can be achieved ...
Aug 22, 2023
0
36
A team at DTU Health Tech, led by Associate Professor Alireza Dolatshahi-Pirouz, has made a leap forward in tissue regeneration by creating a multi-leveled scaffold that encompasses properties of native bone on both the nano, ...
Jun 27, 2023
0
37
Heart failure is a common condition, though it currently lacks a cure. And treatments can only manage symptoms, often with side effects. But recent research published in ACS Biomaterials Science & Engineering could open up ...
Jun 20, 2023
0
21
Inspired by sutures developed thousands of years ago, MIT engineers have designed "smart" sutures that can not only hold tissue in place, but also detect inflammation and release drugs.
May 16, 2023
0
64
Investigators at Cedars-Sinai Cancer found that fatty liver, a condition closely associated with obesity, promotes the spread of colorectal cancer to the liver. Their study, published today in the journal Cell Metabolism, ...
May 11, 2023
0
115
When you need a bit of motivation, it often has to come from within. New research suggests cancer-fighting immune cells have found a way to do just that.
May 8, 2023
0
194
A new chip that holds different cell types in tiny, interconnected chambers could allow scientists to better understand the physiological and disease interactions between organs. The integrated-gut-liver-on-a-chip (iGLC) ...
Apr 7, 2023
0
51
A team of Harvard and Sloan Kettering scientists has developed compounds that can target and degrade proteins associated with acute myeloid leukemia (AML) and nearly doubled the life expectancy of mice with cancer in laboratory ...
Apr 3, 2023
0
74
